about
Laboratory markers in ulcerative colitis: Current insights and future advancesSerum concentration of free T3, free T4 and TSH in healthy childrenThe roles of mediator complex in cardiovascular diseases.Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cellsEpigenetic reprogramming in atherosclerosis.Epigenetic-related therapeutic challenges in cardiovascular disease.The beneficial effects of antioxidant supplementation in enteral feeding in critically ill patients: a prospective, randomized, double-blind, placebo-controlled trial.I219V polymorphism in hMLH1 gene in patients affected with ulcerative colitis.Evidence for anti-inflammatory effects of combined administration of vitamin E and C in older persons with impaired fasting glucose: impact on insulin action.Laccase treatment impairs bisphenol A-induced cancer cell proliferation affecting estrogen receptor alpha-dependent rapid signals.Analysis of PALB2 in a cohort of Italian breast cancer patients: identification of a novel PALB2 truncating mutation.Serum but not salivary cortisol levels are influenced by daily glycemic oscillations in type 2 diabetes.Arg72Pro polymorphism of p53 may predict poor response to medical treatment in ulcerative colitis.Identification of a novel in-frame deletion in BRCA2 and analysis of variants of BRCA1/2 in Italian patients affected with hereditary breast and ovarian cancer.A novel PALB2 truncating mutation in an Italian family with male breast cancer.Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activitiesSerum p53 antibodies assessment may help physicians to follow-up patients with Helicobacter pylori infectionSerum concentrations of intact parathyroid hormone in healthy childrenSerum anti-p53 antibodies in lung cancer: comparison with established tumor markersSerum-soluble E-cadherin fragments in lung cancerCYP17 and CYP19 gene polymorphisms in women affected with endometriosisSerum osteocalcin and parathyroid hormone in healthy children assessed with two new automated assaysArg72Pro p53 polymorphism in Italian women: no association with endometriosisSerum p53 antibodies in patients affected with ulcerative colitisDouble heterozygosity in the BRCA1 and BRCA2 genes in Italian family
P50
Q27027022-0EAEF492-88A0-4FCC-A69D-202F26F85682Q28215760-88D880E4-C6A7-4C98-812F-93C75E76CA5AQ34416269-23EC6C05-A360-49DF-A031-E0F661AF5D56Q37280567-17A81F6A-4296-4C21-8851-BA6290A22561Q38272645-0EF3BD0B-D8A9-4A93-B108-7E0FA61305D9Q38372796-9E52C3C9-CFC4-4281-8605-0442CECA6B52Q45034026-AB156165-0588-4471-A9FB-03C51B003F3DQ45043556-9855E2D8-A059-4C51-B640-9F228C1613A3Q46269131-988DB6FA-3EEF-4F20-99EB-ABE1BD7717A5Q46393891-1771DDA6-36DA-4648-9C93-DB58C8CAC728Q50961264-FA2E698B-89FC-45EA-ABD3-28666311FADAQ51294866-1EDE1622-C74E-4E90-BAB4-B144C19BFAB2Q54172972-A36C344C-0C0A-4680-891D-1D4BD9491D3DQ54286290-78A51595-A1C6-442F-A817-55305BE09A92Q55069160-7E311886-6FD3-48AD-80A1-8C07049F0A8EQ58862252-EFFCAF3A-CEB0-43F8-9180-8096F1EC4EADQ73348624-A1DA26C2-4895-47EE-B409-917885BB3DF6Q73854421-68AFFC5D-BB07-4FC6-8C67-76A02B3EF61FQ74498690-36A1D9CC-9379-47AC-BBFB-3FD649A2D467Q77400750-6D5AA4BF-A19E-4669-9712-2BCEF5B1BFA4Q79636742-4B3C8769-86D8-4D23-8111-D2D20125980BQ79659387-B8BBC4A3-035E-4662-B1E4-8449AEA32CCFQ80106755-44E180AC-583C-49B3-8AE1-93E6EE1A22A1Q80837970-5B23C2D6-282E-408E-AC5A-8BECA91CEC6EQ87244824-0C60DB7A-5C76-4BCB-A5EE-D59CBB5A01E9
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-7849-9970
@en
name
Maria Teresa Vietri
@ast
Maria Teresa Vietri
@en
Maria Teresa Vietri
@es
Maria Teresa Vietri
@nl
type
label
Maria Teresa Vietri
@ast
Maria Teresa Vietri
@en
Maria Teresa Vietri
@es
Maria Teresa Vietri
@nl
prefLabel
Maria Teresa Vietri
@ast
Maria Teresa Vietri
@en
Maria Teresa Vietri
@es
Maria Teresa Vietri
@nl
P106
P21
P31
P496
0000-0001-7849-9970